M
MBX Biosciences, Inc. (MBX)
NMS – Real vaqt narxi. Valyuta: USD
36.98
-3.10 (-7.73%)
Yopilishda: May 12, 2026, 4:00 PM EDT
37.03
+0.05 (0.14%)
Bozor oldidan: May 13, 2026, 8:12 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
36.98
-3.10 (-7.73%)
Yopilishda: May 12, 2026, 4:00 PM EDT
37.03
+0.05 (0.14%)
Bozor oldidan: May 13, 2026, 8:12 AM EDT
MBX Biosciences, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, endokrin va metabolik kasalliklarni davolash uchun aniq peptid terapiyalarini kashf qilish va ishlab chiqishga qaratilgan. Uning asosiy dori nomzodi Canvuparatide (MBX 2109) bo'lib, bu paratiroid gormonining peptidli pro-dori bo'lib, surunkali gipoparatiroidizmni davolash uchun 3-bosqichli klinik sinovdan o'tmoqda. Kompaniya, shuningdek, bariatrik jarrohlikning surunkali asoratlari bo'lgan post-bariatrik gipoglikemiyani davolash uchun potentsial terapiya sifatida 2-bosqichli klinik sinovda bo'lgan uzoq muddatli ta'sir qiluvchi glyukagon-o'xshash peptid-1 (GLP-1) retseptor antagonistini - Imapextide (MBX 1416) ishlab chiqmoqda. Bundan tashqari, u semizlik va unga bog'liq kasalliklarni davolash uchun yangi dori-darmonlarni ishlab chiqishga imkon beradigan tadqiqotlarda bo'lgan asosiy semizlik dori nomzodi MBX 4291ni ishlab chiqmoqda. Kompaniya 2018-yilda tashkil etilgan va Indiana shtatining Carmel shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Andreas Moraitis M.D. | Senior Vice President of Clinical Development |
| Dr. Chatan Charan Ph.D. | Senior VP of Pharmaceutical Development & Chemistry, Manufacturing and Controls |
| Dr. Michael A. Dorato DABT, Ph.D. | Sr. Vice President of Discovery & Non-Clinical Development |
| Dr. Salomon Azoulay M.D. | Chief Medical Officer |
| Mr. John W. Smither CPA | Interim Chief Financial Officer |
| Mr. Mark Hope | Senior Vice President of Regulatory & Quality |
| Mr. Pete De Spain | Senior Vice President of Investor Relations & Corporate Communications |
| Mr. Peter Kent Hawryluk MBA | CEO, President & Director |
| Mr. Steven L. Hoerter | Executive Chairperson |
| Ms. Michelle Graham | Chief Human Resources Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-11 | 8-K | mbx-20260511.htm |
| 2026-05-08 | DEFA14A | mbx_proxy_supplement_202.htm |
| 2026-05-07 | 8-K | mbx-20260507.htm |
| 2026-04-22 | DEFA14A | defa_14a_2026.htm |
| 2026-04-22 | DEF 14A | mbx-20260421.htm |
| 2026-03-12 | S-3ASR | mbx-20260312.htm |
| 2026-03-12 | 8-K | mbx-20260312.htm |
| 2026-03-09 | 8-K | mbx-20260309.htm |
| 2026-02-27 | 8-K | mbx-20260224.htm |
| 2026-02-05 | 8-K | mbx-20260204.htm |